User description

Pharmaceutical & Biologics advances in pharmaceuticals and biologics have improved the health of countless people, reduced the occurrence of preventable diseases, and allowed for persistent diseases to preserved over an extended period of time. These advances have extended life span for countless individuals, particularly those with chronic diseases and some cancers.However, the intensifying costs of pharmaceuticals and biologics places these interventions and treatments out of reach for far too lots of people. Policies must be established that allow buyers of health care, consisting of Medicare, to work out the costs of prescription drugs. In addition, there need to be greater flexibility in the design of formularies that enable increased usage of generic and bio-similar items.